Afshari JT et al. determined the role of Interleukin-6 (IL-6) and Tumour Necrosis Factor-alpha (TNF-α), markers of immune activation and endothelial dysfunction, in patients with preeclampsia. The gene discussed is IL6; the disease is preeclampsia.